Total Payments
$4,704
2024 Payments
$15.00
Companies
20
Transactions
68
Medicare Patients
133
Medicare Billing
$23,006
Payment Breakdown by Category
Consulting$2,200 (46.8%)
Food & Beverage$1,869 (39.7%)
Other$600.00 (12.8%)
Education$35.40 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,200 | 1 | 46.8% |
| Food and Beverage | $1,869 | 64 | 39.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $600.00 | 1 | 12.8% |
| Education | $35.40 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $2,469 | 5 | $0 (2019) |
| GENZYME CORPORATION | $600.00 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $330.58 | 10 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $286.38 | 11 | $0 (2018) |
| Seattle Genetics, Inc. | $217.27 | 8 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $195.28 | 2 | $0 (2019) |
| Millennium Pharmaceuticals, Inc. | $108.54 | 2 | $0 (2017) |
| PFIZER INC. | $97.46 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $74.99 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $63.92 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.00 | 1 | Alexion Pharmaceuticals, Inc. ($15.00) |
| 2019 | $2,526 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($2,288) |
| 2018 | $854.55 | 35 | Novartis Pharmaceuticals Corporation ($198.30) |
| 2017 | $1,308 | 22 | GENZYME CORPORATION ($600.00) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $15.00 | General |
| Category: Rare Disease | ||||||
| 04/24/2019 | Genentech USA, Inc. | GAZYVA (Biological), Rituxan Hycela | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: BioOncology | ||||||
| 03/20/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Oncology | ||||||
| 02/22/2019 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $37.55 | General |
| Category: ONC | ||||||
| 02/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: Oncology | ||||||
| 02/21/2019 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $109.40 | General |
| Category: HEMATOLOGY | ||||||
| 02/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $87.85 | General |
| Category: Oncology | ||||||
| 02/14/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| Category: Oncology | ||||||
| 01/23/2019 | Genentech USA, Inc. | GAZYVA (Biological), Rituxan Hycela | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: BioOncology | ||||||
| 01/16/2019 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 01/08/2019 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Oncology | ||||||
| 12/12/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, Erleada | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Oncology | ||||||
| 11/21/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Oncology | ||||||
| 11/15/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: Oncology | ||||||
| 11/06/2018 | Genentech USA, Inc. | Rituxan Hycela (Biological) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: BioOncology/Immunology | ||||||
| 10/17/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $8.03 | General |
| 10/03/2018 | PFIZER INC. | XALKORI (Drug), IBRANCE, VIZIMPRO | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2018 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Oncology | ||||||
| 09/12/2018 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/14/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.29 | General |
| 07/30/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Oncology | ||||||
| 07/11/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, Erleada | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Oncology | ||||||
| 07/10/2018 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 31 | 57 | $14,837 | $4,543 |
| 2022 | 4 | 102 | 148 | $48,407 | $18,464 |
Total Patients
133
Total Services
205
Medicare Billing
$23,006
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 25 | $7,925 | $2,447 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 32 | $6,912 | $2,096 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 71 | $22,507 | $8,650 | 38.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $12,894 | $4,395 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 43 | $9,288 | $3,756 | 40.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 13 | $3,718 | $1,663 | 44.7% |
About Dr. Olga Derman, M.D
Dr. Olga Derman, M.D is a Hematology & Oncology healthcare provider based in Boise, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356553101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Olga Derman, M.D has received a total of $4,704 in payments from pharmaceutical and medical device companies, with $15.00 received in 2024. These payments were reported across 68 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($2,200).
As a Medicare-enrolled provider, Derman has provided services to 133 Medicare beneficiaries, totaling 205 services with total Medicare billing of $23,006. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Boise, ID
- Active Since 05/04/2007
- Last Updated 02/25/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356553101
Products in Payments
- NINLARO (Drug) $2,363
- MOZOBIL (Drug) $600.00
- ADCETRIS (Biological) $217.27
- DEFITELIO (Drug) $109.40
- PREVYMIS (Drug) $107.52
- TASIGNA (Drug) $99.02
- DIFICID (Drug) $96.38
- Defitelio (Drug) $85.88
- DARZALEX (Biological) $70.30
- ZINPLAVA (Biological) $67.14
- BOSULIF (Drug) $64.56
- EMPLICITI (Biological) $55.79
- RYDAPT (Drug) $51.99
- Yescarta (Drug) $37.55
- GAZYVA (Biological) $35.04
- Imbruvica (Drug) $29.65
- XGEVA (Biological) $26.53
- Venclexta (Drug) $23.00
- BESPONSA (Biological) $20.40
- Kyprolis (Biological) $20.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boise
Dr. Cannon Milani, Md, MD
Hematology & Oncology — Payments: $6,519
Hematology & Oncology $6,519
Andrew Pierson, Md, MD
Hematology & Oncology — Payments: $4,586
Hematology & Oncology $4,586
Dr. Kerry Pulver, Md,Phd, MD,PHD
Hematology & Oncology — Payments: $3,241
Hematology & Oncology $3,241
William Kreisle, Md, MD
Hematology & Oncology — Payments: $1,081
Hematology & Oncology $1,081
Shane Ahlers, M.d, M.D
Hematology & Oncology — Payments: $787.10
Hematology & Oncology $787.10
Dan Zuckerman, Md, MD
Hematology & Oncology — Payments: $716.63
Hematology & Oncology $716.63